The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines
Yukio Nishimura, Biborka Bereczky, Mayumi OnoVolume:
127
Langue:
english
Pages:
13
DOI:
10.1007/s00418-007-0281-y
Date:
May, 2007
Fichier:
PDF, 940 KB
english, 2007
File converter
Plus de résultats de recherche
More benefits 
